Compare ACXP & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACXP | INHD |
|---|---|---|
| Founded | 2017 | 2019 |
| Country | United States | Hong Kong |
| Employees | 4 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 9.6M |
| IPO Year | 2021 | 2023 |
| Metric | ACXP | INHD |
|---|---|---|
| Price | $2.00 | $1.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $95.50 | N/A |
| AVG Volume (30 Days) | 112.3K | ★ 16.6M |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.61 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,846,250.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 221.43 |
| 52 Week Low | $0.29 | $0.06 |
| 52 Week High | $8.34 | $15.90 |
| Indicator | ACXP | INHD |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 58.46 |
| Support Level | $1.89 | $1.01 |
| Resistance Level | $2.30 | $1.64 |
| Average True Range (ATR) | 0.15 | 0.15 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 53.19 | 13.64 |
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.